Delivery Order SPE2DB20D2014-SPE2DB23FC28U
Award Date
5/19/23
Potential Completion Date
5/22/23
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 500 tablets of Atorvastatin 80 mg. The contract, valued at $1,959.14, is a firm fixed-price delivery order with a completion date of January 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, SPE2DB20D1004|SPE2DB23FG6S1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,866.19 firm fixed-price delivery order is for the supply of 4,562,331,415 tablets of 40mg Atorvastatin, a generic cardiovascular medication. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.38 Firm Fixed Price delivery order is for 4,567,490,649 units of 10 mg Atorvastatin tablets. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.22, is for the delivery of 4560784583 units of Atorvastatin 40 mg tablets to support military healthcare programs. The award is a Delivery Order contract with a firm-fixed price pricing type, with a completion date of May 2, 2023. This contract is not designated as a set-aside and was...
This federal contract award, valued at $2,337.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 20 mg tablets in quantities of 1,000 per order, with a completion date of November 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,228.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,906,764 units of Atorvastatin 40 mg tablets, a common cardiovascular medication. The award does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,294.35 firm fixed-price contract is for the delivery of 90-count atorvastatin 80 mg tablets. No set-aside was used for this award. Amerisourcebergen will provide this drug product to support the medical needs of military treatment facilities and other DLA customers through September 2024. This order is part of Amerisourcebergen's larger Indefinite...
This federal contract award, valued at $3,223.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4,562,417,388 units of Atorvastatin 40 mg tablets, with a period of performance through October 10, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This federal contract award, valued at $1,668.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,600 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...